Evidence map›Paper›PMID 36432187›Full record

ArticleMolecules (Basel, Switzerland)2022

Metabolomic Profiling, Antioxidant and Enzyme Inhibition Properties and Molecular Docking Analysis of Antarctic Lichens.

Alfredo Torres-Benítez, José Erick Ortega-Valencia, Marta Sanchez, Pradeep Kumar Divakar, Mario J Simirgiotis, María Pilar Gómez-Serranillos

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Biological potential ofFrontiers in pharmacology · 2025
    Article
  7. Biological activities ofFrontiers in pharmacology · 2024
    Article
  8. Screening the Extract ofMolecules (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alfredo Torres-BenítezInstituto de Farmacia, Facultad de Ciencias, Campus Isla Teja, Universidad Austral de Chile, Valdivia 5090000, Chile.ORCID 0000-0002-0881-8187
José Erick Ortega-ValenciaTecnológico Nacional de México/Instituto Tecnológico de Tlalnepantla, Av. Instituto Tecnológico, S/N. Col. La Comunidad, Tlalnepantla de Baz 54070, Mexico.
Marta SanchezDepartamento de Farmacología, Farmacognosia y Botánica, Facultad de Farmacia, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, Ciudad Universitaria, 28040 Madrid, Spain.
Pradeep Kumar DivakarDepartamento de Farmacología, Farmacognosia y Botánica, Facultad de Farmacia, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, Ciudad Universitaria, 28040 Madrid, Spain.ORCID 0000-0002-0300-0124
Mario J SimirgiotisInstituto de Farmacia, Facultad de Ciencias, Campus Isla Teja, Universidad Austral de Chile, Valdivia 5090000, Chile.ORCID 0000-0003-4552-3123
María Pilar Gómez-SerranillosDepartamento de Farmacología, Farmacognosia y Botánica, Facultad de Farmacia, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, Ciudad Universitaria, 28040 Madrid, Spain.ORCID 0000-0002-9178-3420

Funding

Instituto Antático Chileno INACH RT 16-17
6 · The paper itself

Abstract

The lichen species

Indexed as

EczemaKeratosisLichensAntioxidantsCholinesterasesMolecular Docking SimulationAntioxidantsCholinesterasesAntarcticaantioxidantbioactive compoundsenzyme inhibitionLecanianeuroprotective potentialPseudephebeSphaerophorus

Identifiers

PMID36432187
PMCPMC9692326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.